Multivitamins Plus Magnesium Reduce Pregnancy Complications in Preeclampsia Study

Preeclampsia affects up to 8% of pregnancies and significantly increases risks for both mothers and babies, making effective treatments crucial for long-term health outcomes. This randomized controlled trial investigated whether adding multivitamin supplementation to standard magnesium therapy could improve results in preeclampsia management.

Researchers studied 194 pregnant women with preeclampsia, randomly assigning half to receive standard intravenous magnesium sulfate treatment alone, while the other half received the same magnesium therapy plus one daily multivitamin tablet for two weeks. The team measured blood pressure, protein loss, placental blood flow, blood clotting function, and maternal-infant outcomes.

The combination therapy group showed remarkable improvements: 23% lower urinary protein levels, significantly better placental blood flow with reduced resistance in umbilical and spiral arteries, and improved blood clotting markers. Most importantly, these women experienced fewer serious complications including 54% less postpartum hemorrhage, 57% fewer low birth weight babies, and 57% fewer NICU admissions. Benefits were most pronounced in severe preeclampsia cases.

These findings suggest that comprehensive nutritional support during high-risk pregnancies may optimize both immediate outcomes and long-term health trajectories for mothers and children. Proper nutrition during pregnancy influences lifelong health patterns, making these results relevant for longevity and healthspan optimization. However, this study focused specifically on preeclampsia patients in a clinical setting, so broader applications require further research.